Amsurg Corp (AMSG) Misses Q2 EPS by 4c, Updates Guidance

Amsurg Corp (NASDAQ: AMSG) reported Q2 EPS of $0.59, $0.04 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $281 million versus the consensus estimate of $281.51 million.

Amsurg Corp sees Q3 2014 EPS of $0.63-$0.65, versus the consensus of $0.67.

Amsurg Corp sees FY2014 EPS of $2.61-$2.66, versus the consensus of $2.53. Amsurg Corp sees FY2014 revenue of $1.61-1.63 billion, versus the consensus of $1.65 billion.

For earnings history and earnings-related data on Amsurg Corp (AMSG) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c